VIAMUNE
ViaMune offers a fully synthetic vaccine platform that generates robust immune responses to tumor-specific targets. ViaMune's patented technology provides a unique path to targeting structures found only on tumor cells. ViaMune is seeking financing to complete IND submission, achieve Phase 1 milestones and advance its pipeline. ViaMune is anchored by a leadership team with deep experience in oncology and pharmaceutical development.
VIAMUNE
Industry:
Biotechnology
Founded:
2011-06-01
Address:
Athens, Attiki, Greece
Country:
Greece
Website Url:
http://www.viamune.com
Total Employee:
1+
Status:
Active
Technology used in webpage:
Viewport Meta SPF Microsoft Exchange Online Office 365 Mail Common Name Invalid GoDaddy DNS ASP.NET IIS IIS 10 ASP.NET 4.0
Similar Organizations
Adze Biotechnology
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers.
aratinga.bio
aratinga.bio is a preclinical-stage biotech company developing novel immunotherapies to treat cancer.
DCPrime
DCPrime is a clinical stage company which develops novel cancer immunotherapies based on its DCOne platform technology.
Current Employees Featured
Official Site Inspections
http://www.viamune.com
- Host name: 67.141.69.216.host.secureserver.net
- IP address: 216.69.141.67
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "ViaMune"
ViaMune - Crunchbase Company Profile & Funding
ViaMune offers a fully synthetic vaccine platform that generates robust immune responses to tumor-specific targets. ViaMune's patented technology provides a unique path to targeting …See details»
ViaMune, Inc. | Athens, GA, US Startup - Gust
Jun 1, 2011 · ViaMune is a preclinical-stage company with a mission to enable immunotherapy for patients with advanced cancers. Find investment information and connect with ViaMune, Inc., …See details»
ViaMune Company Profile 2024: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for ViaMune. Use the PitchBook Platform to explore the full profile.See details»
Georgia Research Alliance - GRA
ViaMune Industry: Immunotherapies to treat cancer. ViaMune is developing an immunotherapy vaccine targeting tumor-specific MUC1, a cell-surface glycoprotein that helps cancerous cells …See details»
ViaMune Company Profile - Office Locations, Competitors ... - Craft
ViaMune is a company engaged in the development of an immunotherapy vaccine. Its solutions targets tumor-specific MUC1, a cell-surface glycoprotein that helps cancerous cells form a …See details»
VIAMUNE, INC. Company Profile | Athens, GA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VIAMUNE, INC. of Athens, GA. Get the latest business insights from Dun & Bradstreet.See details»
ViaMune - Products, Competitors, Financials, Employees, …
ViaMune is a preclinical-stage company with a mission to enable immunotherapy for patients with advanced cancers. Use the CB Insights Platform to explore ViaMune's full profile.See details»
ViaMune - Overview, News & Similar companies | ZoomInfo.com
Who is ViaMune. ViaMune, Inc., based in Athens, Georgia, is a privately-held preclinical stage company with a mission to enable immunotherapy for patients with adv anced cancers. …See details»
ViaMune, Inc. - CMOCRO
ViaMune, Inc. is a privately-held preclinical stage company with a mission to enable immunotherapy for patients with advanced cancers. ViaMune is anchored by a leadership …See details»
Contact us:
A website created by GoDaddy’s Website Builder Website BuilderSee details»
ViaMune - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ViaMune is a preclinical-stage company with a mission to enable immunotherapy for patients with advanced cancers.See details»
ViaMune - Contacts, Employees, Board Members, Advisors & Alumni
ViaMune is a preclinical-stage company with a mission to enable immunotherapy for patients with advanced cancers.See details»
Scientists develop vaccine that attacks breast cancer in mice
Dec 12, 2017 · Biotechnology is a key industry in Georgia, and this year Boons founded Athens-based company Viamune to help develop and commercialize the vaccine and the technologies …See details»
VIAMUNE, INC. - VentureRadar
Dec 24, 2020 · As an agricultural biotech company at the forefront of semiochemical development, our innovative approach to insect control is revolutionizing the farming industry …See details»
Alex Harvey - CEO - Viamune - LinkedIn
With a 3 year post-doc position completed, I was hired as a founding scientist of AviGenics which went on to become SynaGeva Biopharma, a biotech company that was acquired by Alexion in …See details»
GeoVax, Inc. And ViaMune To Collaborate On Cancer ... - BioSpace
Nov 8, 2016 · ViaMune, Inc., based in Athens, Georgia, is a privately-held preclinical stage company with a mission to enable immunotherapy for patients with advanced cancers. …See details»
Research programme: cancer immunotherapies - ViaMune
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. ViaMune is developing immunotherapies for the treatment of cancer. The …See details»
GeoVax Presents Preliminary Data for Cancer Vaccine - Yahoo …
Aug 30, 2017 · GeoVax and ViaMune are collaborating with the goal of developing a tumor MUC1 vaccine that can produce a broad spectrum of anti-tumor antibody and T cell responses.See details»
GeoVax and ViaMune to Collaborate on Cancer Immunotherapy …
Nov 7, 2016 · GeoVax and ViaMune will combine efforts in order to produce efficacious levels of CTLs in a greater percentage of patients, thus enabling more patients to benefit from CPI …See details»
GeoVax and ViaMune to Collaborate on Cancer ... - Pipelinereview
Nov 8, 2016 · ViaMune, Inc., based in Athens, Georgia, is a privately-held preclinical stage company with a mission to enable immunotherapy for patients with advanced cancers. …See details»